These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10385497)

  • 21. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
    Frick MH; Syvänne M; Nieminen MS; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Taskinen MR
    Circulation; 1997 Oct; 96(7):2137-43. PubMed ID: 9337181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL receptor proline664 to leucine mutation.
    Takahashi K; Kobayashi J; Bujo H; Takahashi M; Taira K; Kaneko K; Tashiro J; Shinomiya M; Miyazaki A; Saito Y
    Intern Med; 2000 Oct; 39(10):804-9. PubMed ID: 11030204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.
    Shah SJ; Waters DD; Barter P; Kastelein JJ; Shepherd J; Wenger NK; DeMicco DA; Breazna A; LaRosa JC
    J Am Coll Cardiol; 2008 May; 51(20):1938-43. PubMed ID: 18482661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The benefit of aggressive lipid lowering.
    Brown WV
    Atheroscler Suppl; 2000 Sep; 1(1):15-9. PubMed ID: 11285716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Fujii S; Yasuda T; Watanabe Y
    J Thorac Cardiovasc Surg; 2000 May; 119(5):1008-13; discussion 1013-4. PubMed ID: 10788822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid lowering and coronary bypass graft surgery.
    Campeau L
    Curr Opin Cardiol; 2000 Nov; 15(6):395-9. PubMed ID: 11198621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial quantitative coronary analyses for the evaluation of one-year change in saphenous vein grafts.
    Suzuki N; Kozuma K; Ueno Y; Nagaoka K; Kyono H; Ishikawa S; Watanabe H; Yokoyama N; Takeshita S; Isshiki T
    Ann Thorac Surg; 2008 Feb; 85(2):525-9. PubMed ID: 18222257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.
    Mukamal KJ; Girotra S; Mittleman MA
    Am Heart J; 2006 Feb; 151(2):368-72. PubMed ID: 16442902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trial.
    Abdel-Karim AR; Da Silva M; Lichtenwalter C; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Makke L; Jeroudi OM; Raghunathan D; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    Int J Cardiol; 2013 Oct; 168(3):2468-73. PubMed ID: 23561918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of polymorphisms in five genes to long-term aortocoronary saphenous vein graft patency.
    Ellis SG; Chen MS; Jia G; Luke M; Cassano J; Lytle B
    Am J Cardiol; 2007 Apr; 99(8):1087-9. PubMed ID: 17437732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
    J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.